Depression and Anxiety Trial, Recruiting NCT06506253 Sponsor: University of Utah Condition: Depression and Anxiety
Back to Depression And Anxiety

Depression and Anxiety Trial, Recruiting

NCT06506253
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 to 64 years old (male or female)
  • People who are medically stable
  • People whose primary diagnosis is Generalised Anxiety Disorder (GAD)
  • People who score 15 or higher on a standard anxiety rating scale called the HAM-A
  • People who have either been off psychiatric medications for at least 2 weeks before the study starts, or have been on a stable dose of their current medication for at least 6 weeks and are willing to keep that dose unchanged
  • People who are able to lie flat on their front or back for up to one hour at a time, as the study involves massage treatment
  • People who have a permanent home address
  • People who are able to follow the research study schedule and requirements
  • People who are able to understand and sign an approved consent form in line with federal and institutional guidelines

Who may not be able to join:

  • People who have used nicotine or illicit drugs within the past 3 months, or who take regular or long-term medications that the study doctor believes could affect the results
  • People who are pregnant (based on self-report; no pregnancy testing is done as part of the study)
  • People who are normally asleep during the day, such as those working night shifts, or who have other habits that regularly disrupt their normal daily sleep-wake cycle
  • People who have been on a strict diet of fewer than 1,200 calories per day for 2 or more days in a row within the past month
  • People who have drunk heavily on a regular basis in the month before screening, defined as having 5 or more drinks within 2 hours, or 7 or more drinks within 24 hours, happening twice a month or more
  • People who started psychotherapy or complementary and alternative medicine (CAM) treatments for psychological distress within the 90 days before screening
  • People who have ever been diagnosed with PTSD, bipolar disorder, OCD, or a psychotic disorder, or who currently have an alcohol or substance use disorder
  • People who currently have thoughts of harming themselves or others
  • People who get massages regularly, defined as averaging 4 or more massages per year over the past 5 years
  • People who are currently using any other hands-on or holistic complementary therapies to treat a health concern
  • People with a history of head injury or neurological condition that, in the study doctor's opinion, could affect the results or make participation unsafe
  • People who have a history of cancer that required chemotherapy or radiation treatment
  • People who are unable to have an MRI scan — this includes people with a cardiac pacemaker, hearing implant, any metal in their body or eyes (such as pins, screws, shrapnel, plates, braces, or dentures), or tattoos on the head including permanent makeup, as these may interfere with getting clear images
  • People with medical, psychiatric, or cognitive conditions that may affect their ability to understand the study, give consent, or complete the study requirements
  • People who are currently taking part in another research study (with the exception of large observational studies such as 'All of Us')

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Mark Rapaport, University of Utah

Phone: 801-587-8626

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 May 2024
Est. completion
1 July 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Pre-to-post-treatment change in resting state functional connectivity

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov